Loading profile…
Loading profile…
Adam Sragovicz — CFO · IntelliCheck · San Diego, California, United States.
Direct contact
1 verified contact method on file — work email. Masked until you unlock.
Free account, no card required. Your first unlock is on us.
Profile updated Nov 2026 · Sourced from public professional profiles · Legitimate-interest B2B basis
Or explore more contacts in this database — from 45 credits.
About
Public-company CFO with 15+ years leading finance, capital markets, SEC reporting, and board governance across software, identity verification, biotech, SPACs, and specialty finance. Currently CFO of Intellicheck (Nasdaq: IDN). Co-founder and CFO (Advisory) of Avimer Bio. Previously CFO and director of Murphy Canyon Acquisition Corp., where I led the ~$132M Nasdaq IPO and the ~$720M business combination with Conduit Pharmaceuticals; earlier CFO of Presidio Property Trust through its IPO and follow-on capital raises; and VP Treasury at Encore Capital Group, supporting roughly $2B of debt and equity financing and global cash management. Focus areas include GAAP and SEC reporting, SOX and internal controls, audit-committee engagement, investor relations, capital allocation, and complex transactions (IPO, SPAC, M&A, equity and debt). Yale B.A. CFM, Merrill Lynch Donald T. Regan School of Advanced Financial Management. Executive Member, Latino Corporate Directors Association. Based in San Diego. Open to public-company board and audit-committee opportunities.
Experience
Chief Financial OfficerCurrent
Intellicheck · San Diego, CA
Aug 2024 – Present
• Lead SEC reporting, GAAP financials, and SOX/internal controls for Intellicheck (Nasdaq: IDN). • Partner with the Board and investors on capital allocation, forecasting, and acquisition/partnership evaluation. • Own budgeting, FP&A, risk/compliance, and investor communications for a public identity-verification company.
Co-Founder & Chief Financial Officer (advisory)Current
Avimer Bio · San Diego, CA
Feb 2023 – Present
• Co-founded and led business development and fundraising efforts • Focused business on Precision Protein Design and Structural Biology, enhancing the company's market position as Nature’s Structure for Targeted Medicines®
Education
Skills
Related professionals · IntelliCheck